Breast and Ovarian Cancer Risk Evaluation Clinic

Appointments
Dr. Erin Cobain looks at an MRI of a breast

News and Stories

See more news about cancer genetics & breast cancer
Computer screens and microscope pictured in a laboratory setting.
Health Lab

Understanding family history key to early detection of pancreatic cancer

How genetic testing and family history help identify individuals at high risk for pancreatic cancer, enabling earlier screening and better treatment outcomes.
graphic drawing of woman falling and everything is pink and falling and floating with her like dna strands, cars, people, medicine, ID, blood vessels and cells
Health Lab

Why are more young people being diagnosed with cancer?

An article discusses causes of early-onset cancer and ways to reduce your risk.
jill martin close up blonde hair pink background and pink shirt
Health Lab

Jill Martin’s breast cancer journey

TODAY show contributor Jill Martin talks about breast cancer treatment and why she’s advocating for early detection and genetic screening.
two women, one older one younger, looking concerned listening to a provider across from them with back to camera
Health Lab

Many breast cancer survivors don't receive genetic testing, despite being eligible

As cancer treatment and survivorship care relies more on understanding the genetic make up of an individual’s tumor, a study from the University of Michigan Health Rogel Cancer Center finds that many breast cancer survivors who meet criteria for genetic counseling and testing are not receiving it.
Cancer Aware surrounded by a circle of multicolor ribbons
Cancer Aware

Family Health History as Cancer Prevention

Drs. Elena Stoffel and Jennifer Griggs, co-principal investigators of the Michigan Genetic Hereditary Testing (MiGHT) Study, discuss the importance of knowing your family health history.
older person pouring pills into hand close up
Health Lab

Early findings suggest this cancer drug may be effective against advanced tumors caused by genetic mutations

Sparrow Health System, part of University of Michigan Health, experts release findings in a study of a cancer drug for patients with genetic mutations.